Mega Genomics Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Revenue	159.71	151.3	145.73	237.19	203.22	123.7
Revenue Growth (YoY)	8.66%	3.82%	-38.56%	16.71%	64.28%	-
Cost of Revenue	67.1	63	64	70.51	56.98	45.22
Gross Profit	92.62	88.3	81.72	166.68	146.24	78.48
Selling, General & Admin	65.65	75.21	77.79	45.95	35.4	20.22
Other Operating Expenses	1.21	0.78	2.48	5.87	3.8	8.45
Operating Expenses	60.61	62.01	106.13	57.98	38.47	35.12
Operating Income	32.01	26.28	-24.4	108.69	107.77	43.35
Interest Expense	-1.79	-1.12	-0.72	-6.91	-16.55	-19.59
Interest & Investment Income	5.72	6.07	4.01	2.98	0.34	0.04
Currency Exchange Gain (Loss)	0.1	1.44	11.75	-	-	-
Other Non Operating Income (Expenses)	0.89	3.51	-12.06	-8.94	3.24	14.49
EBT Excluding Unusual Items	36.92	36.18	-21.42	95.82	94.8	38.29
Gain (Loss) on Sale of Investments	-	-	-	0.06	0.1	-
Pretax Income	36.92	36.18	-21.42	95.88	94.9	38.29
Income Tax Expense	5.03	6.14	-3.8	16.87	15.81	8.6
Net Income	31.89	30.04	-17.62	79.02	79.1	29.69
Net Income to Common	31.89	30.04	-17.62	79.02	79.1	29.69
Net Income Growth	-	-	-	-0.10%	166.40%	-
Shares Outstanding (Basic)	206	212	206	127	-	-
Shares Outstanding (Diluted)	206	212	206	127	-	-
Shares Change (YoY)	-4.83%	2.65%	62.09%	-	-	-
EPS (Basic)	0.15	0.14	-0.09	0.62	-	-
EPS (Diluted)	0.15	0.14	-0.09	0.62	-	-
Free Cash Flow	87.53	127.83	-11.92	26.47	101.79	36.69
Free Cash Flow Per Share	0.42	0.60	-0.06	0.21	-	-
Gross Margin	57.99%	58.36%	56.08%	70.27%	71.96%	63.44%
Operating Margin	20.04%	17.37%	-16.75%	45.83%	53.03%	35.05%
Profit Margin	19.97%	19.85%	-12.09%	33.31%	38.92%	24.00%
Free Cash Flow Margin	54.81%	84.49%	-8.18%	11.16%	50.09%	29.66%
EBITDA	40	34.54	-16.08	117.05	116.31	51.93
EBITDA Margin	25.05%	22.83%	-11.03%	49.35%	57.23%	41.98%
D&A For EBITDA	7.99	8.26	8.33	8.36	8.53	8.57
EBIT	32.01	26.28	-24.4	108.69	107.77	43.35
EBIT Margin	20.04%	17.37%	-16.75%	45.83%	53.03%	35.05%
Effective Tax Rate	13.62%	16.97%	-	17.59%	16.66%	22.46%
Advertising Expenses	-	-	-	-	14.1	0.3

Source: S&P Global Market Intelligence. Standard template. Financial Sources.